Celsion Corp (CLSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
Celsion Corp (Celsion) is an oncology company with focus on developing portfolio of new cancer treatments, including directed chemotherapies, RNA and DNA based therapies and immunotherapies. The company develops drugs using its’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), TheraPlas and TheraSilence. Its lead product candidate ThermoDox is a proprietary form of doxorubicin based LTSL technology in Phase III clinical trial for the treatment of primary liver cancer. It is also developing a comprehensive pipeline of targeted therapeutic agents for cancer. Celsion is headquartered in Lawrenceville, New Jersey, the US.
Nov 15, 2021: Celsion Reports Third Quarter 2021 Financial Results
Sep 17, 2021: Celsion and Hainan Poly Pharm sign agreement to manufacture Celsion’s DNA-based Vaccine
Aug 12, 2021: Celsion Reports Second Quarter 2021 Financial Results and Provides Business Update
Jul 15, 2021: Celsion expands vaccine advisory board with the addition of Dr. Dan H. Barouch and Dr. Luke D. Handke
Jun 21, 2021: Celsion Corp. Enters into $10 Million Strategic Loan Facility with Silicon Valley Bank
You get detailed information about the company and its operations to identify potential customers and suppliers.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Gain key insights into the company for academic or business research.
Note: Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Celsion Corp (Celsion) is an oncology company with focus on developing portfolio of new cancer treatments, including directed chemotherapies, RNA and DNA based therapies and immunotherapies. The company develops drugs using its’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), TheraPlas and TheraSilence. Its lead product candidate ThermoDox is a proprietary form of doxorubicin based LTSL technology in Phase III clinical trial for the treatment of primary liver cancer. It is also developing a comprehensive pipeline of targeted therapeutic agents for cancer. Celsion is headquartered in Lawrenceville, New Jersey, the US.
Celsion Corp Key Recent Developments
Nov 15, 2021: Celsion Reports Third Quarter 2021 Financial Results
Sep 17, 2021: Celsion and Hainan Poly Pharm sign agreement to manufacture Celsion’s DNA-based Vaccine
Aug 12, 2021: Celsion Reports Second Quarter 2021 Financial Results and Provides Business Update
Jul 15, 2021: Celsion expands vaccine advisory board with the addition of Dr. Dan H. Barouch and Dr. Luke D. Handke
Jun 21, 2021: Celsion Corp. Enters into $10 Million Strategic Loan Facility with Silicon Valley Bank
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company- Celsion Corp - Key Facts
- Celsion Corp - Key Employees
- Celsion Corp - Key Employee Biographies
- Celsion Corp - Major Products and Services
- Celsion Corp - History
- Celsion Corp - Company Statement
- Celsion Corp - Locations And Subsidiaries
- Head Office
- Company Overview
- Celsion Corp - Business Description
- Celsion Corp - SWOT Analysis
- SWOT Analysis - Overview
- Celsion Corp - Strengths
- Celsion Corp - Weaknesses
- Celsion Corp - Opportunities
- Celsion Corp - Threats
- Celsion Corp - Key Competitors
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
- Celsion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
- Celsion Corp, Recent Deals Summary
- Nov 15, 2021: Celsion Reports Third Quarter 2021 Financial Results
- Sep 17, 2021: Celsion and Hainan Poly Pharm sign agreement to manufacture Celsion’s DNA-based Vaccine
- Aug 12, 2021: Celsion Reports Second Quarter 2021 Financial Results and Provides Business Update
- Jul 15, 2021: Celsion expands vaccine advisory board with the addition of Dr. Dan H. Barouch and Dr. Luke D. Handke
- Jun 09, 2021: Celsion Appoints Christine A. Pellizzari to its Board of Directors
- Jun 08, 2021: Celsion Corporation Appoints Dr. Stacy R. Lindborg to its Board of Directors
- Jun 04, 2021: Celsion Corp. Announces Adjournment of Annual Meeting
- May 27, 2021: Celsion Urges All Shareholders to Vote at the 2021 Annual Meeting to be Held on Friday June 4, 2021
- May 14, 2021: Celsion Corporation Reports First Quarter 2021 Financial Results and Provides Business Update
- May 07, 2021: Celsion to Hold First Quarter 2021 Financial Results and Business Update Conference Call on Friday, May 14, 2021
- Methodology
- Ratio Definitions
- About the Publisher
List of Tables
- Celsion Corp, Key Facts
- Celsion Corp, Key Employees
- Celsion Corp, Key Employee Biographies
- Celsion Corp, Major Products and Services
- Celsion Corp, History
- Celsion Corp, Key Competitors
- Celsion Corp, Ratios based on current share price
- Celsion Corp, Annual Ratios
- Celsion Corp, Interim Ratios
- Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
- Celsion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
- Celsion Corp, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
List of Figures
- Celsion Corp, Performance Chart (2016 - 2020)
- Celsion Corp, Ratio Charts
- Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
- Celsion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amgen Inc
- Bristol-Myers Squibb Co
- Clovis Oncology Inc
- Tesaro Inc
- Merck & Co Inc
- US Oncology Research Llc
- Genentech USA Inc
